Drugs & Biologicals: Maximum Allowed Units (MAUs) – Palmetto GBA Medicare
CPT CODE description
J7030 – Infusion, normal saline solution , 1000 cc
Maximum Allowed Units List – 2
KEY
|
HCPCS Code
|
Code Description
|
MAU
|
Release Date
|
Reassesment
Date |
---|---|---|---|---|---|
J1956 | Injection, levofloxacin, 250 mg | 3 | 11/14/2008 | ||
J1980 | Injection, hyoscyamine sulfate, up to 0.25 mg | 6 |
12/16/2008 |
||
J2001 | Injection, lidocaine HCl for intravenous infusion, 10 mg | 210 | 12/16/2008 | ||
J2010 | Injection, lincomycin HCl, up to 300 mg | 7 |
12/3/2008 |
||
J2020 | Injection, linezolid, 200
mg |
3 | 7/17/2009 | ||
J2060 | Injection, lorazepam, 2 mg | 4 | 12/16/2008 | ||
J2150 | Injection, mannitol, 25% in 50 ml | 8 |
12/16/2008 |
7/1/2010 | |
J2175 | Injection, meperidine HCl, per 100 mg | 3 | 12/3/2008 | ||
4 | J2180 |
Injection, meperidine and promethazine HCl, up to 50
mg |
0 |
11/21/2008 |
|
J2185 | Injection, meropenem, 100 mg | 88 | 12/16/2008 | ||
J2210 | Injection, methylergonovine maleate, up to 0.2 mg | 3 |
12/16/2008 |
7/1/2010 | |
J2250 | Injection, midazolam hydrochloride, per 1 mg | 22 | 12/16/2008 | ||
J2270 | Injection, morphine sulfate, up to 10 mg | 3 |
11/14/2008 |
7/1/2010 | |
J2271 | Injection, morphine sulfate, 100 mg | 1 | 11/14/2008 | ||
5 | J2275 |
Injection, morphine sulfate (preservative-free sterile
solution), per 10 mg |
15 |
12/3/2008 |
|
J2280 | Injection, moxifloxacin, 100
mg |
4 | 7/17/2009 | ||
J2300 | Injection, nalbuphine HCl, per 10 mg | 16 | 11/14/2008 | ||
J2310 | Injection, naloxone hydrochloride, per 1 mg | 10 |
12/16/2008 |
||
J2320 | Injection, nandrolone deconoate, up to 50 mg | 4 | 12/16/2008 | ||
J2321 | Injection, nandrolone deconoate, up
to 100 mg |
2 | 7/17/2009 | ||
J2322 | Injection, nandrolone decanoate, up
to 200 mg |
1 | 4/1/2010 | ||
J2323 | Injection, natalizumab, 1 mg | 300 | 11/14/2008 | ||
J2353 |
Injection, octreotide, depot form for intramuscular injection, 1 mg |
30 | 12/16/2008 | Denied | |
3 | J2354 |
Injection, octreotide, non-depot form for subcutaneous or
intravenous injection, 25 mcg |
0 |
12/16/2008 | |
J2355 | Injection, oprelvekin, 5 mg | 1 | 11/14/2008 | ||
5 | J2357 | Injection, omalizumab, 5 mg |
75 |
12/16/2008 | |
J2360 | Injection, orphenadrine citrate, up to 60 mg | 1 | 12/3/2008 | ||
J2405 | Injection, ondansetron hydrochloride, per 1 mg | 50 | 12/16/2008 | ||
J2410 |
Injection, oxymorphone HCl, up to 1 mg |
5 | 12/16/2008 | ||
J2430 | Injection, pamidronate disodium, per 30 mg | 3 | 11/14/2008 | ||
J2440 |
Injection, papaverine HCl, up to 60 mg |
2 | 11/14/2008 | ||
J2460 | Injection, oxytetracycline HCl, up
to 50 mg |
5 | 7/17/2009 | ||
J2469 | Injection, palonosetron HCl, 25 mcg | 10 | 11/14/2008 | ||
J2503 | Injection, pegaptanib sodium, 0.3 mg | 2 |
11/14/2008 |
||
J2505 | Injection, pegfilgrastim, 6 mg | 1 | 11/7/2008 | ||
J2510 |
Injection, penicillin G procaine, aqueous, up to 600,000
units |
4 |
11/14/2008 |
7/1/2010 | |
J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125
grams (1.125 grams) |
12 | 12/16/2008 | 6/1/2010 | |
J2550 | Injection, promethazine HCl, up to 50 mg | 3 |
12/3/2008 |
||
J2562 | Injection, plerixafor, 1
mg |
40 | 1/1/2010 | ||
J2597 | Injection, desmopressin acetate, per 1 mcg | 32 | 12/16/2008 | ||
4 |
J2650 |
Injection, prednisolone acetate, up to 1 ml | 0 | 11/21/2008 | |
3 | J2675 |
Injection, progesterone, per 50 mg |
0 | 11/21/2008 | |
J2680 | Injection, fluphenazine decanoate, up to 25 mg | 4 | 11/14/2008 | ||
J2690 |
Injection, procainamide HCl, up to 1 gram |
1 | 11/14/2008 | ||
J2720 | Injection, protamine sulfate, per 10 mg | 5 | 11/14/2008 | ||
J2760 |
Injection, phentolamine mesylate, up to 5 mg |
1 | 11/14/2008 | ||
J2765 | Injection, metoclopramide HCl, up to 10 mg | 132 | 12/16/2008 | ||
J2778 |
Injection, ranibizumab, 0.1 mg |
10 | 12/16/2008 | ||
J2780 | Injection, ranitidine hydrochloride, 25 mg | 4 | 12/16/2008 | ||
8 | J2785 |
Injection, regadenoson, 0.1 mg |
4 | 12/16/2008 | |
J2788 |
Injection, RHo D immune globulin,
human, minidose, 50 micrograms |
1 | 7/1/2010 | ||
J2790 |
Injection, RHo D immune globulin, human, full dose, 300
micrograms (1500 IU) |
1 | 11/14/2008 | ||
J2791 |
Injection, RHo D immune globulin, human, IM or IV, 100
IU |
275 | 7/1/2010 | ||
J2792 |
Injection, RHo D immune globulin, intravenous, human, solvent detergent, 100 IU |
300 | 11/14/2008 | 7/1/2010 | |
5 | J2793 | Injection, rilonacept, 1
mg |
440 | 1/1/2010 | |
J2794 | Injection, risperidone, long acting, 0.5 mg | 100 | 11/14/2008 | ||
5 | J2795 | Injection, ropivacaine hydrochloride, 1 mg | 300 |
12/16/2008 |
|
5 | J2796 | Injection, romiplostim, 10
micrograms |
150 | 1/1/2010 | |
J2800 | Injection, methocarbamol, up to 10 ml | 2 | 12/3/2008 | ||
J2805 | Injection, sincalide, 5 micrograms | 1 |
11/14/2008 |
||
5 |
J2820 | Injection, sargramostim (GM-CSF), 50 mcg | 15 | 11/14/2008 |
2/17/2009 |
J2910 |
Injection, aurothioglucose, up to 50 mg | 1 | 11/14/2008 | ||
4 | J2912 |
Injection, sodium chloride, 0.9%, per 2 ml |
0 | 11/14/2008 | |
J2916 |
Injection, sodium ferric gluconate complex in sucrose
injection, 12.5 mg |
10 | 12/16/2008 | ||
J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
83 | 12/16/2008 | ||
J2930 |
Injection, methylprednisolone sodium succinate, up to 125
mg |
27 | 12/16/2008 | ||
3 | J2941 |
Injection, somatropin, 1 mg |
0 | 11/21/2008 | |
J2950 | Injection, promazine HCl, up to 25 mg | 8 | 12/16/2008 | ||
J2997 |
Injection, alteplase recombinant, 1 mg |
100 | 12/16/2008 | ||
J3000 | Injection, streptomycin, up to 1 gram | 2 | 12/3/2008 | ||
5 | J3010 |
Injection, fentanyl citrate, 0.1 mg |
3 | 12/3/2008 | |
3 | J3030 |
Injection, sumatriptan succinate, 6 mg (only for direct
physician supervision administration) |
0 |
11/21/2008 | |
J3070 | Injection, pentazocine, 30 mg | 4 | 12/16/2008 | ||
1 | J3100 | Injection, tenecteplase, 50
mg |
1 | 7/17/2009 | |
8 |
J3101 | Injection, tenecteplase, 1 mg | 50 | 12/16/2008 | |
J3105 | Injection, terbutaline sulfate, up to 1 mg | 1 |
11/14/2008 |
||
J3120 | Injection, testosterone enanthate, up to 100 mg | 4 | 12/3/2008 | ||
J3130 | Injection, testosterone enanthate, up to 200 mg | 2 |
11/14/2008 |
||
4 |
J3140 | Injection, testosterone suspension, up to 50 mg | 0 | 11/21/2008 | |
4 |
J3150 |
Injection, testosterone propionate, up to 100 mg | 0 | 11/21/2008 | |
J3230 |
Injection, chlorpromazine HCl, up to 50 mg |
4 | 12/16/2008 | ||
J3240 |
Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg
vial |
1 | 11/14/2008 | ||
J3243 |
Injection, tigecycline, 1 mg |
100 | 11/14/2008 | ||
J3250 | Injection, trimethobenzamide HCl, up to 200 mg | 2 | 11/14/2008 | ||
J3260 |
Injection, tobramycin sulfate, up to 80 mg |
5 | 12/16/2008 | ||
J3265 | Injection, torsemide, 10 mg/ml | 2 | 11/14/2008 | ||
8 | J3300 |
Injection, triamcinolone acetonide, preservative free, 1 mg |
40 | 12/16/2008 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified,
per 10 mg |
16 | 12/16/2008 | ||
4 | J3302 |
Injection, triamcinolone diacetate, per 5 mg |
0 | 11/21/2008 | |
J3303 | Injection, triamcinolone hexacetonide, per 5 mg | 12 | 12/16/2008 | 4/10/2009 | |
J3315 |
Injection, triptorelin pamoate, 3.75 mg |
6 | 11/14/2008 | 7/1/2010 | |
J3360 | Injection, diazepam, up to 5 mg |
6 |
12/16/2008 | ||
J3370 | Injection, vancomycin HCl, 500 mg | 8 | 12/16/2008 | 9/18/2009 | |
J3396 | Injection, verteporfin, 0.1 mg |
150 |
12/16/2008 | ||
J3410 | Injection, hydroxyzine HCl, up to 25 mg | 12 | 12/16/2008 | ||
J3411 | Injection, thiamine HCl, 100 mg | 1 | 11/21/2008 | ||
J3420 |
Injection, vitamin B-12 cyanocobalamin, up to 1000 mcg |
1 | 11/21/2008 | ||
J3430 | Injection, phytonadione (vitamin K), per 1 mg | 100 | 12/16/2008 | ||
J3470 |
Injection, hyaluronidase, up to 150 units |
2 | 11/21/2008 | ||
J3471 |
Injection hyaluronidase, ovine, preservative free, per 1 usp
unit (up to 999 USP units) |
400 | 12/16/2008 | ||
J3473 | Injection, hyaluronidase,
recombinant, 1 USP unit |
300 | 7/17/2009 | ||
J3475 | Injection, magnesium sulfate, per 500 mg | 48 |
12/16/2008 |
||
J3480 | Injection, potassium chloride, per 2 mEq | 60 | 12/16/2008 | ||
J3486 | Injection, ziprasidone mesylate, 10 mg | 4 |
11/21/2008 |
||
J3487 | Injection, zoledronic acid, 1 mg | 4 | 12/3/2008 | ||
J3488 | Injection, zoledronic acid, 1 mg | 5 |
11/21/2008 |
||
2 |
J3520 | Edetate disodium, per 150 mg | 0 | 11/21/2008 | |
2 |
J3535 |
Drug administered through a metered dose inhaler | 0 | 11/21/2008 | |
J7030 |
Infusion, normal saline solution, 1000 cc |
2 | 12/16/2008 | ||
J7040 |
Infusion, normal saline solution, sterile (500 ml = 1
unit) |
4 | 12/3/2008 | ||
J7042 |
5% dextrose/normal saline solution (500 ml = 1 unit) |
4 | 12/3/2008 | ||
J7050 | Infusion, normal saline solution , 250 cc | 8 | 12/16/2008 | ||
J7060 |
5% dextrose/water (500 ml = 1 unit) |
4 | 12/3/2008 | ||
J7070 | Infusion, D5W, 1000 cc | 2 | 11/21/2008 | ||
J7100 | Infusion, dextran 40, 500
ml |
2 | 7/1/2010 | ||
J7110 | Infusion, dextran 75, 500
ml |
2 | 7/1/2010 | ||
J7120 | Ringers lactate infusion, up to 1000 cc | 4 |
12/3/2008 |
7/1/2010 | |
2 |
J7130 |
Hypertonic saline solution, 50 or 100 mEq, 20 cc
vial |
0 | 11/21/2008 | |
5 | J7185 | Injection, factor VII
(antihemophilic factor, recombinant) (Xyntha), per I.U. |
5500 | 1/1/2010 | |
8 | J7186 |
Injection, antihemophilic factor VIII/Von Willebrand factor
complex (human), per factor VIII IU |
5500 |
12/16/2008 | |
5 | J7192 |
Factor VIII (antihemophilic factor, recombinant) per
IU |
5500 | 12/16/2008 | |
2 | J7300 | Intrauterine copper contraceptive |
0 |
11/21/2008 | |
2 | J7302 |
Levonorgestrel-releasing intrauterine contraceptive system, 52
mg |
0 | 11/21/2008 | |
J7308 |
Aminolevulinic acid HCl for topical administration, 20%,
single unit dosage form |
2 | 11/21/2008 | ||
J7311 |
Fluocinolone acetonide, intravitreal implant (Retisert) |
1 | 11/21/2008 | 4/1/2010 | |
2 | J7317 |
Sodium hyaluronate, per 20 to 25 mg dose for intra-articular
injection |
0 |
11/21/2008 | |
J7321 |
Hyaluronan or derivative, Hyalgan or Supartz, for
intra-articular injection, per dose |
2 | 11/21/2008 | ||
9 | J7322 |
Hyaluronan or derivative, Synvisc, for intra-articular
injection, per dose |
2 |
11/21/2008 | |
J7323 |
Hyaluronan or derivative, Euflexxa, for intra-articular
injection, per dose |
2 | 11/21/2008 | ||
J7324 |
Hyaluronan or derivative, Orthovisc, for intra-articular
injection, per dose |
2 |
11/21/2008 |
||
J7325 |
Hyaluronan or derivative, Synvisc or Synvisc-One, for
intra-articular injection, 1 mg |
96 | 1/1/2010 | ||
2 | J7502 | Cyclosporine, oral 100 mg | 0 | 12/16/2008 | |
2 | J7506 | Prednisone, oral, per 5 mg |
0 |
12/16/2008 | |
2 | J7510 | Prednisolone, oral, per 5 mg | 0 | 12/16/2008 | |
J7513 | Daclizumab, parenteral, 25 mg | 5 | 11/21/2008 | ||
2 | J7515 |
Cyclosporine, oral, 25 mg |
0 | 12/16/2008 | |
7 | J7602 |
Albuterol, all formulations including separated isomers,
inhalation, solution, FDA-approved final product, non-compounded, administered through DME, concentrated form, per 1 mg (albuterol) or per 0.5 mg (levalbuterol) |
3 |
12/16/2008 | |
7 | J7603 |
Albuterol, all formulations including separated isomers,
inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose, per 1 mg (albuterol) or per 0.5 mg (levalbuterol) |
3 | 12/16/2008 | |
8 | J7606 |
Formoterol fumarate, inhalation solution, FDA-approved final
product, non-compounded, administered through DME, unit dose form, 20 micrograms |
1 |
12/16/2008 | |
J7607 |
Levalbuterol, inhalation solution, compounded product,
administered through DME, concentrated form, 0.5 mg |
3 |
12/16/2008 |
||
J7615 |
Levalbuterol inhalation solution, compounded product,
administered through DME, unit dose, 0.5 mg |
3 | 12/16/2008 | ||
J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg,
FDA-approved final product, non-compounded, administered through DME |
1 |
12/16/2008 |
||
J7626 |
Budesonide, inhalation solution, FDA-approved final product,
non-compounded, administered trough DME, unit dose form, up to 0.5 mg |
2 | 12/16/2008 | ||
4 | J7628 |
Bitolterol mesylate, inhalation solution, compounded product,
administered through DME, concentrated form, per mg |
0 |
11/21/2008 |
|
4 |
J7636 |
Atropine, inhalation solution, compounded product,
administered through DME, unit dose form, per mg |
0 | 11/21/2008 | |
J7638 |
Dexamethasone, inhalation solution, compounded product,
administered through DME, unit dose form, per mg |
10 | 12/16/2008 | ||
3 | J7639 |
Dornase alpha, inhalation solution, FDA-approved final
product, non-compounded, administered through DME, unit dose form, per mg |
0 | 12/16/2008 | |
3 |
J7641 |
Flunisolide, inhalation solution, compounded product,
administered through DME, unit dose, per milligram |
0 | 12/16/2008 | |
3 | J7643 |
Glycopyrrolate, inhalation solution, compounded product, administered through DME, unit dose, per mg |
0 | 12/16/2008 | |
J7644 |
Ipratropium bromide, inhalation solution, FDA-aapproved final
product, non-compounded, administered through DME, unit dose form, per mg |
1 | 12/16/2008 | ||
J7645 |
Ipratropium bromide, inhalation solution, compounded product, administered through DME, unit dose, per mg |
1 | 12/16/2008 | ||
J7668 |
Metaproterenol sulfate, inhalation solution, FDA-approved
final product, non-compounded, administesred through DME, concentrated form, per 10mg |
2 | 12/16/2008 | ||
J7681 |
Terbutaline sulfate, inhalant solution, compounded product, administered through DME, unit dose form, per mg |
3 | 12/16/2008 | ||
3 | J7685 |
Tobramycin, inhalation solution, compounded product,
administered through DME, unit dose form, per 300mg |
0 |
12/16/2008 | |
2 | J8501 | Aprepitant, oral, 5 mg | 0 | 11/21/2008 | |
2 | J8521 | Capecitabine, oral, 500 mg |
0 |
12/16/2008 | |
2 | J8530 | Cyclophosphamide, oral, 25 mg | 0 | 12/16/2008 | |
2 | J8600 | Melphalan, oral, 2mg |
0 |
12/16/2008 | |
2 | J8700 | Temozolmide, oral 5 mg | 0 | 11/21/2008 | |
2, 8 | J8705 | Topotecan, oral, 0.25 mg |
0 |
12/16/2008 | |
J9000 | Injection, doxorubicin hydrochoride, 10 mg | 18 | 12/16/2008 | ||
J9001 |
Injection, doxorubicin hydrochloride, all lipid formulations,
10 mg |
14 | 11/7/2008 | 7/1/2010 | |
J9010 |
Injection, alemtuzumab, 10 mg |
3 | 11/7/2008 | ||
J9015 | Aldesleukin, per single use vial | 6 | 12/16/2008 | ||
J9017 |
Injection, arsenic trioxide, 1 mg |
20 | 12/3/2008 | 1/12/2009 | |
J9020 | Injection, asparaginase, 10,000 units |
2 |
11/21/2008 | ||
J9025 | Injection, azacitidine, 1 mg | 300 | 12/3/2008 | ||
J9031 | BCG (intravesical), per instillation | 1 | 11/21/2008 | ||
8 | J9033 |
Injection, bendamustine HCl, 1 mg |
300 | 12/16/2008 | |
J9035 | Injection, bevacizumab, 10 mg | 170 | 12/3/2008 | Denied | |
J9040 |
Injection, bleomycin sulfate, 15 units |
4 | 11/21/2008 | ||
J9041 | Injection, bortezomib, 0.1 mg | 35 | 11/7/2008 | ||
J9045 |
Injection, carboplatin, 50 mg |
20 | 11/21/2008 | Denied | |
J9050 | Injection, carmustine, 100 mg |
5 |
12/3/2008 | ||
J9055 | Injection, cetuximab, 10 mg | 120 | 11/7/2008 | 2/27/2009 | |
J9060 | Cisplatin, powder or solution, per 10 mg |
24 |
12/3/2008 | ||
J9062 | Cisplatin, 50 mg | 5 | 11/21/2008 | ||
J9065 | Injection, cladribine, per 1 mg | 11 | 11/21/2008 | 6/1/2010 | |
J9070 |
Cyclophosphamide, 100 mg |
55 | 12/3/2008 | ||
J9080 | Cyclophosphamide, 200 mg | 19 | 12/16/2008 | 7/1/2010 | |
J9090 |
Cyclophosphamide, 500 mg |
11 | 12/3/2008 | ||
J9091 | Cyclophosphamide, 1.0 gram |
6 |
12/3/2008 | ||
J9092 | Cyclophosphamide, 2.0 gram | 3 |
11/21/2008 |
||
J9093 | Cyclophosphamide, lyophilized, 100 mg | 24 | 12/3/2008 |
7/1/2010 |
|
J9094 |
Cyclophosphamide, lyophilized, 200 mg | 19 | 12/16/2008 | 7/1/2010 | |
J9095 |
Cyclophosphamide, lyophilized, 500 mg |
6 | 12/3/2008 | 7/1/2010 | |
J9096 | Cyclophosphamide, lyophilized, 1.0 gram | 4 | 12/3/2008 | 7/1/2010 | |
J9097 | Cyclophosphamide, lyophilized, 2.0 gram | 2 | 11/21/2008 | 7/1/2010 | |
J9098 | Injection, cytarabine liposome, 10 mg | 5 | 11/21/2008 | ||
J9100 | Injection, cytarabine, 100 mg | 3 |
11/21/2008 |
||
J9110 | Injection, cytarabine, 500 mg | 10 | 11/21/2008 | 3/12/2009 | |
J9120 | Injection, dactinomycin, 0.5 mg | 4 |
11/21/2008 |
||
J9130 | Dacarbazine, 100 mg | 10 | 12/3/2008 | 6/12/2009 | |
J9140 | Dacarbazine, 200 mg | 5 |
12/3/2008 |
2/27/2009 | |
J9150 | Injection, daunorubicin, 10 mg | 11 | 12/3/2008 | ||
J9155 | Injection, degarelix, 1
mg |
240 | 1/1/2010 | ||
J9160 |
Injection, denileukin diftitox, 300 micrograms | 7 | 11/21/2008 | ||
9 | J9170 |
Injection, docetaxel, 20 mg |
12 | 11/21/2008 | |
J9171 | Injection, docetaxel, 1
mg |
240 | 1/1/2010 | 1/8/2010 | |
J9178 |
Injection, epirubicin HCl, 2 mg | 150 | 12/16/2008 | ||
J9181 |
Injection, etoposide, 10 mg |
30 | 12/3/2008 | 6/23/2009 | |
J9182 | Etoposide, 100 mg |
3 |
11/21/2008 | ||
J9185 | Injection, fludarabine phosphate, 50 mg | 2 | 11/21/2008 | ||
J9190 | Injection, fluorouracil, 500 mg | 21 | 11/21/2008 | 1/12/2009 | |
J9200 |
Floxuridine, 500 mg |
4 | 12/16/2008 | ||
J9201 | Injection, gemcitabine hydrochloride, 200 mg | 14 | 11/7/2008 | ||
J9202 |
Goserelin acetate implant, per 3.6 mg |
3 | 11/7/2008 | ||
J9206 | Injection, irinotecan, 20 mg | 42 | 11/7/2008 | ||
8 | J9207 |
Injection, ixabepilone, 1 mg |
105 | 12/16/2008 | |
J9208 | Injection, ifosfamide, 1 gram | 6 | 12/3/2008 | 2/27/2009 | |
J9209 |
Injection, mesna, 200 mg |
30 | 12/3/2008 | 2/27/2009 | |
J9211 | Injection, idarubicin hydrochloride, 5 mg |
8 |
12/16/2008 | ||
J9213 | Injection, interferon, alfa-2A, recombinant, 3 million units | 3 | 11/21/2008 | ||
J9214 |
Injection, interferon, alfa-2B, recombinant, 1 million
units |
100 | 11/21/2008 | ||
3 | J9216 |
Injection, interferon, gamma 1-B, 3 million units |
0 | 11/21/2008 | |
J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 6 | 12/16/2008 | 4/24/2009 | |
J9218 | Leuprolide acetate, per 1 mg | 1 | 7/1/2010 | ||
J9219 |
Leuprolide acetate implant, 65 mg | 1 | 12/16/2008 | ||
J9225 |
Histrelin implant, 50 mg |
1 | 12/16/2008 | ||
J9226 | Histrelin implant, 50 mg | 1 | 12/16/2008 | ||
J9230 |
Mechlorethamine HCl, (nitrogen mustard), 10 mg |
5 | 12/16/2008 | ||
J9245 | Injection, melphalan HCl, 50 mg | 1 | 11/21/2008 | ||
J9250 |
Methotrexate sodium, 5 mg |
7200 | 12/16/2008 | ||
J9260 | Methotrexate sodium, 50 mg | 720 | 12/16/2008 | ||
J9263 |
Injection, oxaliplatin, 0.5 mg |
624 | 12/16/2008 | 2/27/2009 | |
J9264 | Injection, paclitaxel protein-bound particles, 1 mg |
624 |
12/16/2008 | ||
J9265 | Paclitaxel, 30 mg | 18 | 12/16/2008 | 2/27/2009 | |
J9268 | Injection, pentostatin, per 10 mg |
1 |
11/21/2008 | ||
J9280 | Mitomycin, 5 mg | 10 | 12/16/2008 | ||
J9290 | Mitomycin, 20 mg | 3 | 11/21/2008 | ||
J9291 |
Mitomycin, 40 mg |
2 | 11/21/2008 | ||
J9293 | Injection, mitoxantrone hydrochloride, per 5 mg | 10 | 12/16/2008 | ||
J9300 |
Injection, gemtuzumab ozogamicin, 5 mg |
5 | 12/3/2008 | ||
J9303 | Injection, panitumumab, 10 mg | 70 | 12/16/2008 | 4/20/2010 | |
J9305 |
Injection, pemetrexed, 10 mg |
120 | 12/3/2008 | ||
J9310 | Injection, rituximab, 100 mg | 11 | 11/7/2008 | ||
J9320 |
Injection, streptozocin, 1 gram |
4 | 12/16/2008 | ||
J9328 | Injection, temozolomide, 1
mg |
500 | 1/1/2010 | ||
8 |
J9330 | Injection, temsirolimus, 1 mg | 25 | 12/16/2008 | |
J9340 | Injection, thiotepa, 15 mg | 6 |
12/3/2008 |
||
J9350 | Injection, topotecan, 4 mg | 10 | 12/3/2008 | 1/12/2009 | |
J9355 | Injection, trastuzumab, 10 mg | 88 |
11/7/2008 |
Denied | |
J9360 | Vinblastine sulfate, 1 mg | 45 | 12/16/2008 | ||
J9370 | Vincristine sulfate, 1 mg | 4 |
12/16/2008 |
||
J9375 | Vincristine sulfate, 2 mg | 2 | 12/3/2008 | ||
J9380 | Vincristine sulfate, 5
mg |
1 | 4/1/2010 | ||
J9390 |
Injection, vinorelbine tartrate, per 10 mg | 8 | 12/3/2008 | ||
J9395 |
Injection, fulvestrant, 25 mg |
20 | 11/21/2008 | 6/1/2010 | |
Q0138 | Injection ferumoxytol, for treatment
of iron deficiency anemia, 1 mg (non-ESRD use) |
510 | 1/1/2010 | ||
Q0139 | Injection ferumoxytol, for treatment
of iron deficiency anemia, 1 mg (for ESRD use) |
510 | 1/1/2010 | ||
9 | Q2024 | Injection, bevacizumab, 0.25
mg |
510 | 10/1/2009 | |
6 | Q4083 | Hyalgan-supartz, per dose | 2 |
11/21/2008 |
|
6 |
Q4084 | Synvisc, per dose | 2 | 11/21/2008 | |
6 |
Q4085 |
Euflexxa, per dose | 2 | 11/21/2008 | |
6 | Q4086 |
Orthovisc, per dose |
2 | 11/21/2008 |
GENERAL INFORMATION
Effective April 1, 2002, CWF edits were implemented to identify HCPCS codes for ambulance services that are either subject to or excluded from Skilled Nursing Facility (SNF) consolidated billing (CB). This coding change added SNF CB edits to CWF to deny payment of some separately billed ambulance services for beneficiaries in a SNF Part A covered stay. Effective July 1, 2003, CWF added an edit to allow claims submitted with specialty type “59” and HCPCS codes J7030 or J7050 (Saline Solution Injection) to process and pay correctly for modifiers other than “NN” when a beneficiary is in a Part A stay, and for claims submitted with an “NN” modifier when the beneficiary is not in a Part A stay. Since the implementation of this update, CMS has identified additional HCPCS codes for drugs and CPT codes for electrocardiogram (EKG) testing that may be separately payable when provided during a SNF ambulance transport that is not subject to SNF CB. HCPCS J-codes (J0000-J9999) not included in previous updates, Q-codes for anti-emetic drugs (Q0163 through Q0181), and CPT codes for EKG testing (93005 and 93041) will be added to the CWF SNF CB bypass for ambulance specialty type “59” carrier claims during the October 2004 SNF CB quarterly update.
Hydration (90760–90761)
Hydration codes are used for reporting intravenous (IV) administration of prepackaged fluid and electrolytes. These codes are not applicable to infusion of drugs or other substances and should not be reported if concurrently administered with chemotherapy or infusions of other drugs. Hydration is typically not a high-risk procedure, and once the IV line is in place, the patient requires little monitoring. Documentation of start and stop times is needed to allow the coder to choose the correct code(s). The codes are based on time, with 90760 for the initial hour and an add-on code of 90761 used for each additional hour.
Supply codes (substance/drug and amount administered) for injections and infusions are documented using a “J” code from HCPCS Level II, such as J7030 for infusion of normal saline solution, 1,000 mL. Some commercial payers do not accept the HCPCS Level II supply codes and will not reimburse for them. In this case, CPT provides a general supply code, 99070, that is submitted along with the name(s) of the product(s) used. To avoid repeating the code for a particular product (e.g., drug), the number of units can be reported in an additional field on the billing form/abstract.
A dehydrated patient is infused with one unit of a 5% dextrose/normal saline solution, which takes approximately 50 minutes: 90760, J7042. Alternatively, supply code 99070 can be used for the product administered if required by the payer (in place of J7042).
CPT provides codes for intravenous push and intra-arterial push. A substance that is pushed is injected directly into an existing IV line that is in use. To use these push codes, the provider must be present for the administration of the substance, or the infusion must take less than 16 minutes to complete. If a push is given subsequent to starting a separate infusion, then the push is coded as subsequent, not as an initial service. If a total infusion lasts less than 16 minutes, the push code is assigned for the service. Push codes cannot be assigned for infusion services that do not meet the time
requirements for add-on codes. For instance, if a patient receives an (initial) infusion for 1 hour 10 minutes, only the initial code of 90765 would be assigned. No add-on or push code can be assigned for the 10 minutes past 1 hour of services.
EXAMPLE Patient presents with severe vomiting and dehydration. IV infusion of normal saline, 1,000 mL for 2 hours. Phenergan IV push given. Report code 90774 for IV push, 90761, 90761 for administration of hydration (normal saline), and the following “J” codes from HCPCS Level II for the products administered: J2550, J7030. (Some payers do not recognize “J” codes, and then the supply code 99070 can be used for the products administered.)